Plassche Douglas bought ELTP
July 3, 2025 · Form 4 insider transaction
Plassche Douglas bought 2,500,000 shares of Elite Pharmaceuticals, Inc. at $0.03 per share, a transaction worth $75.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,500,000
Price
$0.03
Total value
$75.0K
InsiderPlassche Douglas
Role—
SecurityStock Options (right to buy)
Transaction codeM: Option exercise
Transaction dateJuly 3, 2025
Filing dateJuly 8, 2025
Shares owned after2,500,000
OwnershipDirect
10b5-1 planNo
AmendedNo